Back to Search
Start Over
Do Centers for Medicare and Medicaid Services Quality Measures Reflect Cost-Effectiveness Evidence?
- Source :
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 24(11)
- Publication Year :
- 2020
-
Abstract
- Objectives Despite its importance of quality measures used by the Centers for Medicare and Medicaid Services, the underlying cost-effectiveness evidence has not been examined. This study aimed to analyze cost-effectiveness evidence associated with the Centers for Medicare and Medicaid Services quality measures. Methods After classifying 23 quality measures with the Donabedian's structure-process-outcome quality of care model, we identified cost-effectiveness analyses (CEAs) relevant to these measures from the Tufts Medical Center CEA Registry based on the PICOTS (population, intervention, comparator, outcome, time horizon, and setting) framework. We then summarized available incremental cost-effectiveness ratios (ICERs) to determine the cost-effectiveness of the quality measures. Results The 23 quality measures were categorized into 14 process, 7 outcome, and 2 structure measures. Cost-effectiveness evidence was only available for 8 of 14 process measures. Two measures (Tobacco Screening and Hemoglobin bA1c Control) were cost-saving and quality-adjusted life-years (QALYs) improving, and 5 (Depression Screening, Influenza Immunization, Colon Cancer Screening, Breast Cancer Screening, and Statin Therapy) were highly cost-effective (median ICER ≤ $50 000/QALY). The remaining measure (Fall Screening) had a median ICER of $120 000/QALY. No CEAs were available for 15 measures: 10 defined by subjective patient ratings and 5 employed outcome measures without specifying an intervention or process. Conclusions When relevant CEAs were available, cost-effectiveness evidence was consistent with quality measures (measures were cost-effective). Nevertheless, most quality measures were based on subjective ratings or outcome measures, posing a challenge in identifying supporting economic evidence. Refining and aligning quality measures with cost-effectiveness evidence can help further improve healthcare efficiency by demonstrating that they are good indicators of both quality and cost-effectiveness of care.
- Subjects :
- medicine.medical_specialty
Cost effectiveness
media_common.quotation_subject
Cost-Benefit Analysis
Population
Centers for Medicare and Medicaid Services, U.S
03 medical and health sciences
Breast cancer screening
0302 clinical medicine
Health care
medicine
Humans
Quality (business)
030212 general & internal medicine
Quality of care
education
health care economics and organizations
Process Measures
media_common
Quality Indicators, Health Care
education.field_of_study
medicine.diagnostic_test
business.industry
030503 health policy & services
Health Policy
Public Health, Environmental and Occupational Health
United States
Family medicine
Quality-Adjusted Life Years
0305 other medical science
business
Medicaid
Subjects
Details
- ISSN :
- 15244733
- Volume :
- 24
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
- Accession number :
- edsair.doi.dedup.....e9d1e171ea05ecc99c8caf48bf44e6e1